Lipocine Inc. SEC filings LPCN
Lipocine Inc. has 823 filings in SEC EDGAR's recent list, going back to Nov 30, 2011. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 25, 2024 | — |
| CORRESP | Letter to the SEC | Apr 24, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2023 | — |
| 8-A12G | Filing | Mar 10, 2023 | — |
| EFFECT | Filing | Nov 23, 2020 | — |
| CORRESP | Letter to the SEC | Nov 20, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2020 | — |
| PX14A6G | Filing | May 20, 2020 | — |
| PX14A6G | Filing | May 22, 2019 | — |
| EFFECT | Filing | Nov 21, 2017 | — |
| CORRESP | Letter to the SEC | Nov 17, 2017 | — |
| CORRESP | Letter to the SEC | Nov 9, 2017 | — |
| CORRESP | Letter to the SEC | Nov 8, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2017 | — |
| CT ORDER | Filing | Jul 26, 2016 | — |
| EFFECT | Filing | Nov 4, 2014 | — |
| EFFECT | Filing | Oct 14, 2014 | — |
| EFFECT | Filing | Apr 9, 2014 | — |
| CERTNAS | Auto-generated paper document | Mar 19, 2014 | — |
| 8-A12B | Filing | Mar 18, 2014 | — |
| EFFECT | Filing | Nov 25, 2013 | — |
| 8-A12G | Filing | Oct 21, 2013 | — |
| EFFECT | Filing | Sep 26, 2013 | — |
| CT ORDER | Filing | Sep 23, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2013 | — |
| D | Filing | Aug 5, 2013 | — |
| D | Filing | Aug 5, 2013 | — |
| EFFECT | Filing | Feb 13, 2012 | — |
| CORRESP | Letter to the SEC | Feb 10, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2012 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2011 | — |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LPCN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, United States
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1535955
- Former names
- MARATHON BAR CORP (until Jul 9, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.